ABIOMED Inc (NASDAQ:ABMD)
| 235.85 Delayed Data As of May 20 |  -2.80 / -1.17%Today’s Change | 226.46 Today|||52-Week Range 379.30 | -34.33% Year-to-Date |
Latest ABMD News | Press Releases
| Reasons to Retain Abiomed (ABMD) Stock in Your Portfolio For Now May 16 / Zacks.com - Paid Partner Content | Why Abiomed (ABMD) is a Top Growth Stock for the Long-Term May 12 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 238.65 |
| Today’s open | 241.19 |
| Day’s range | 226.69 - 241.19 |
| Volume | 32,017 |
| Average volume (3 months) | 366,146 |
| Market cap | $10.7B |
Data as of 4:04pm ET, 05/20/2022
Growth & Valuation
| Earnings growth (last year) | -39.88% |
| Earnings growth (this year) | +2.34% |
| Earnings growth (next 5 years) | +16.37% |
| Revenue growth (last year) | +21.74% |
| P/E ratio | 81.0 |
| Price/Sales | 14.73 |
| Price/Book | 7.14 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TFXTeleflex Inc | -1.70 | -0.59% |
| PODDInsulet Corp | +3.89 | +2.00% |
| ---- | ||
| SWAVShockwave Medical In... | -1.95 | -1.22% |
Data as of 4:04pm ET, 05/20/2022
Financials
| Next reporting date | July 28, 2022 |
| EPS forecast (this quarter) | $1.05 |
| Annual revenue (last year) | $1.0B |
| Annual profit (last year) | $136.5M |
| Net profit margin | 13.23% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Danvers, Massachusetts |
Forecasts
